Embryology of the Cardiovascular System

Formation of the Cardiac Tube and Heart Fields (Weeks 3-4)

• The primary heart field derives from splanchnic mesoderm lateral to the primitive streak, specifically the epiblast layer that ingresses during gastrulation
• Two endocardial tubes form within the pericardial cavity and fuse in the midline to create a single primitive cardiac tube
• The cardiac tube differentiates into five chambers (from cranial to caudal): truncus arteriosus, bulbus cordis, ventricle, atrium, and sinus venosus
• Early looping (week 4) establishes the basic cardiac architecture—the tube bends rightward (dextral looping), bringing the ventricle ventrally and the atrium dorsally
• The secondary heart field (also called the anterior/splanchnic mesodermal field) contributes to the outflow tract, right ventricle, and atrial septum; failure of this field results in conotruncal abnormalities

Neural Crest Cell Migration and Conotruncal Septation (Weeks 4-7)

• Neural crest cells originating from the pharyngeal arches (particularly arches 1, 3, 4, and 6) migrate ventromedially into the bulbus cordis and truncus arteriosus
• These cells proliferate to form the conal and truncal septa, which divide the outflow tract into the aorta and pulmonary artery
• Abnormal neural crest migration or apoptosis results in conotruncal defects including tetralogy of Fallot, transposition of the great arteries, and truncus arteriosus
• Neural crest cells also contribute to the aortic arch arteries, cardiac neural crest, and parasympathetic innervation
• Molecular signaling via Notch, Wnt, and BMP pathways directs neural crest differentiation; mutations in these pathways (e.g., NOTCH1) cause syndromic CHD

Atrial and Ventricular Septation (Weeks 4-7)

• The atrial septum forms through tissue resorption, growth of multiple septa (septum primum, secundum, and sinus venosus), and involves endocardial cushion tissue
• The endocardial cushions (derivative of cardiac neural crest and second heart field) thicken via epithelial-to-mesenchymal transition (EMT), divide the AV canal, and contribute to atrial and ventricular septa
• Inadequate endocardial cushion development results in AV canal defects (ostium primum ASD, complete AV septal defect)
• The ventricular septum develops from three components: the muscular septum (myocardial growth), the membranous septum (endocardial cushion derivatives), and the conal septum (neural crest-derived)
• Defects in these three zones produce different anatomic types of ventricular septal defects (VSDs)—perimembranous, muscular, or conal VSDs
• TBX5 and GATA4 transcription factors regulate septal growth; mutations cause Holt-Oram syndrome and familial cardiac defects, respectively

Valvulogenesis (Weeks 5-9)

• Valve development occurs through EMT of endocardial cells lining the AV groove and outflow tract, creating mesenchymal cell masses that gradually resorb to form thin, competent leaflets
• The aortic and pulmonic valves derive from neural crest-derived mesenchyme organized into three cusps, whereas mitral and tricuspid valves develop from endocardial cushion tissue
• Abnormal resorption of valve tissue results in stenotic lesions, whereas excessive resorption may cause regurgitation
• Notch signaling controls endothelial EMT; mutations in NOTCH1 cause bicuspid aortic valve, the most common congenital valve lesion (1-2% of population)
• Maternal infection (especially rubella) during this critical window can disrupt valve development, causing patent ductus arteriosus (PDA) and pulmonary stenosis

Septation of the Truncus Arteriosus (Weeks 4-6)

• The truncus arteriosus is divided into the aorta, pulmonary artery, and coronary arteries by the aorticopulmonary septum, which spirals distally
• This septation depends critically on neural crest cell migration and proliferation from the pharyngeal region
• Abnormalities result in truncus arteriosus (single arterial trunk), transposition of the great arteries (TGA; anterior positioning of aorta), and tetralogy of Fallot (anteriorly positioned conal septum)
• DiGeorge syndrome (22q11 deletion) disrupts neural crest development and commonly presents with conotruncal defects

Formation of the Aortic Arch System (Weeks 4-7)

• Six pairs of pharyngeal arch arteries are bilaterally symmetrical, with each connecting the ventral aorta to the dorsal aortae
• Selective regression and remodeling of these six arches establish the definitive aortic arch and branch vessels
• Arch 1: largely regresses (small stapedial artery remnant)
• Arch 2: regresses except for stapedius artery ligament
• Arch 3: forms the common carotid and proximal internal carotid arteries
• Arch 4 (left): forms the definitive aortic arch (between left common carotid and left subclavian)
• Arch 4 (right): forms the right subclavian artery
• Arch 6 (left): forms the left pulmonary artery and ductus arteriosus (patent ductus arteriosus remnant)
• Arch 6 (right): regresses
• Aberrant resorption patterns cause vascular rings and anomalous origin of coronary arteries

Pulmonary and Systemic Circulation Specification (Weeks 5-8)

• The right heart initially develops as the primary pump; the left heart grows from the primary heart field and becomes dominant
• Endothelin-1 signaling from the endoderm drives right heart and pulmonary circuit development; disruption causes hypoplastic left heart syndrome and right-sided lesions
• FGF signaling from the outflow tract mesenchyme promotes left heart growth; insufficiency results in left-sided obstructive lesions

Fetal Circulation and Transitional Changes (Weeks 8-Birth)

• The foramen ovale (patent foramen ovale, PFO) is an interatrial communication between the septum primum (valve-like) and septum secundum that allows right-to-left shunting in utero, bypassing the unexpanded lungs
• The ductus arteriosus is a fetal vessel derived from the left sixth pharyngeal arch artery that shunts blood from the pulmonary artery to the descending aorta, bypassing collapsed fetal lungs
• The ductus venosus shunts umbilical venous blood directly into the inferior vena cava, bypassing hepatic circulation
• At birth, with the first breath, pulmonary vascular resistance falls, systemic vascular resistance rises, and placental circulation ceases, causing reversal of shunt direction
• Functional closure of the foramen ovale and ductus arteriosus occurs within hours to days; anatomic closure (formation of septum secundum-primum fusion and fibrosis of ductal tissue) takes weeks to months
• Patent foramen ovale (PFO) persists in ~25% of adults as a probe-patent communication, clinically relevant for paradoxical embolism; patent ductus arteriosus (PDA) remains hemodynamically significant in premature infants

Coronary Artery Development (Weeks 5-20)

• Coronary arteries arise from the aortic sinuses (specifically the sinuses of Valsalva) through endothelial sprouting and ingrowth from aortic epicardial tissue
• Two main coronary arteries develop: the left main coronary artery (dividing into LAD and LCx) and the right coronary artery, establishing the epicardial network
• Anomalous origin of coronary arteries (e.g., anomalous origin of left main from right sinus of Valsalva) occurs in ~1 per 300 autopsy studies and can cause sudden cardiac death during exertion
• The coronary arterial bed continues to develop throughout fetal life, with myocardial perfusion initially dependent on fetal collaterals

Conduction System Development (Weeks 4-20)

• The sinoatrial (SA) node differentiates from the sinus venosus, specifically from tissue at the junction of the superior and inferior vena cavae
• The atrioventricular (AV) node develops at the AV canal from specialized myocardium derived from the endocardial cushions
• The bundle of His arises from the muscular ventricular septum as a specialized conduction pathway
• The Purkinje fibers branch throughout the ventricular myocardium, ensuring coordinated contraction
• Abnormal conduction system development contributes to heart block, pre-excitation syndromes, and arrhythmias

Genetic Factors

• Chromosomal abnormalities: Down syndrome (trisomy 21; 40-50% have CHD, commonly AV canal defects), Edwards syndrome (trisomy 18; severe polyvalvular disease and VSD), Patau syndrome (trisomy 13; VSD and complex lesions), Turner syndrome (45,X; bicuspid aortic valve, coarctation of aorta), and Marfan syndrome (FBN1 mutation; aortic root dilatation and aortic dissection)

• Microdeletion syndromes: DiGeorge/22q11 deletion syndrome (85% have cardiac involvement; conotruncal defects including tetralogy of Fallot, truncus arteriosus, and interrupted aortic arch); Williams syndrome (7q11 deletion; supravalvular aortic stenosis and peripheral pulmonary stenosis)

• Single gene mutations: GATA4, TBX5, NKX2.5 (transcription factors causing familial CHD and septal defects), NOTCH1 (bicuspid aortic valve, aortic stenosis), FBN1 (Marfan syndrome), KCNQ1 (long QT), MYH7 (hypertrophic cardiomyopathy), LMNA (dilated cardiomyopathy with conduction disease)

• Familial clustering: Recurrence risk ~3-4% if one sibling affected, ~10% if one parent affected, much higher in monozygotic twins

Environmental and Maternal Factors

• Maternal infections during first trimester (particularly weeks 3-8): Rubella (PDA, pulmonary stenosis, cataracts, deafness—classic triad), cytomegalovirus, varicella zoster virus, and parvovirus B19

• Maternal metabolic disorders: Pre-gestational diabetes mellitus (increases CHD risk 2-10 fold; associated with transposition of great arteries, hypoplastic left heart, and caudal regression syndrome), maternal phenylketonuria (PKU; hypoplasia of left heart)

• Maternal medication exposures: ACE inhibitors and ARBs (especially second/third trimester; renal dysgenesis, oligohydramnios, growth restriction, and potential cardiac hypoplasia), thalidomide (conotruncal defects), anticonvulsants (phenytoin, valproic acid; fetal hydantoin syndrome with conotruncal defects), lithium (Ebstein anomaly of tricuspid valve; relative risk ~20-fold), retinoids (teratogenic; cardiac and CNS defects), maternal alcohol use disorder (fetal alcohol spectrum disorder; septal defects, hypoplastic left heart)

• Maternal substance use: Cocaine (inhibits neural crest migration; conotruncal defects and septal defects), amphetamines, tobacco smoking (modest increased risk of septal defects)

• Maternal nutrition: Folic acid deficiency (increases risk of septal defects; prevention with periconceptional supplementation), maternal obesity (increased risk of multiple defect types)

• Maternal age: Advanced maternal age associated with increased chromosomal abnormalities and CHD risk

Environmental Exposures

• Gestational infections: Untreated maternal syphilis, toxoplasmosis, listeriosis

• Radiation exposure: Ionizing radiation during weeks 3-8 (critical period) increases risk of CHD, particularly at doses >10 rad; concern mainly historical or in occupational/accident settings

• Hypoxia and altitude: Chronic maternal hypoxia (e.g., high altitude residence, smoking) associated with slightly increased CHD and PDA risk

Parental and Demographic Factors

• Advanced paternal age: Modest associations with some defect types (spontaneous mutations)

• Maternal age: Both very young (<15 years) and advanced (>40 years) maternal age increase CHD risk

• Consanguinity: Increased risk in families with autosomal recessive genetic conditions

• Ethnicity and geography: Slight variation in prevalence (Hispanic and Asian populations slightly lower; Native American populations higher), likely reflecting genetic variation and ascertainment bias

Prenatal Presentation

• Abnormal fetal echocardiography during routine obstetric ultrasound (weeks 18-24): four-chamber view abnormalities, abnormal outflow tract views, discordant great arteries, absence of foramen ovale
• Polyhydramnios: Seen in severe CHD with poor cardiac output (e.g., hypoplastic left heart, severe aortic stenosis) reducing fetal urine output, paradoxically sometimes increased urine output with cardiac dysfunction
• Fetal growth restriction: Complicates significant left-sided obstructive lesions and severe cardiomyopathy
• Fetal arrhythmia: Detected on fetal echocardiography (e.g., complete heart block in maternal anti-Ro/La antibody-associated congenital heart block)

Neonatal/Infant Presentation (0-12 months)

• Excessive weight gain and failure to thrive: Despite adequate caloric intake (high-output cardiac failure from left-to-right shunts; PDA, ASD, VSD), presenting at 2-8 weeks of age as ductal structures close and pulmonary vascular resistance normalizes
• Tachypnea and work of breathing: Increased respiratory rate (>60 breaths/min), subcostal and intercostal retractions, nasal flaring, grunting
• Hepatomegaly: Passive hepatic congestion from right heart failure; typically firm, smooth, non-tender edge extending >2 cm below costal margin
• Pulmonary rales or crackles: Basilar predominance indicating

Screening (asymptomatic newborn)

• Pulse oximetry CCHD screening: endorsed by the AAP/AHA and part of the US Recommended Uniform Screening Panel; performed at ≥24 hours of life with pre-ductal (right hand) and post-ductal (foot) probes. A saturation <90% in either limb is an immediate fail; saturations of 90–94% in both limbs, or a pre-/post-ductal difference >3%, is a fail if it persists on three measurements an hour apart. Detects ductal-dependent lesions before circulatory collapse, not lesions with normal saturation (small VSD, coarctation with a widely patent duct).
• Fetal echocardiography (typically 18–22 weeks) for abnormal four-chamber or outflow views on obstetric ultrasound, pre-gestational maternal diabetes, teratogen exposure, or a first-degree relative with CHD.

Confirmatory testing

• Transthoracic echocardiography with color Doppler: the gold standard. Defines the segmental anatomy (atrial situs, AV and ventriculo-arterial connections), shunt direction, gradient across obstructive lesions, and ductal patency. Order it before any invasive study.
• Hyperoxia test: with 100% FiO₂, a PaO₂ that stays below roughly 100 mmHg indicates fixed intracardiac right-to-left shunting; a large rise favors parenchymal lung disease. Useful when echo is not immediately available.

Adjunctive findings that matter

• Chest radiograph: boot-shaped heart with decreased pulmonary vascularity (tetralogy of Fallot), egg-on-a-string narrow mediastinum (d-TGA), snowman/figure-of-8 (supracardiac TAPVR), figure-3 sign and inferior rib notching (coarctation).
• ECG: axis and hypertrophy patterns — left axis deviation with RVH in AV septal defect, RVH in TOF.
• Cardiac MRI/CT for great-vessel and arch anatomy; cardiac catheterization reserved for hemodynamics — Qp:Qs and pulmonary vascular resistance with vasoreactivity testing determine operability.
• Genetics: chromosomal microarray, plus targeted testing for 22q11.2 deletion in conotruncal lesions.

Immediate stabilization of the ductal-dependent newborn

• Prostaglandin E1 (alprostadil) infusion: maintains or reopens the ductus arteriosus in ductal-dependent pulmonary flow (pulmonary atresia, critical PS, severe TOF), ductal-dependent systemic flow (HLHS, critical coarctation, interrupted arch), and d-TGA. Start it on clinical suspicion — before echo confirmation if the infant is in shock or profoundly cyanotic. Anticipate apnea, hypotension, and fever; have airway support ready.
• Avoid excess supplemental oxygen in single-ventricle or parallel-circulation physiology: oxygen is a pulmonary vasodilator and steals systemic output into the lungs.
• Balloon atrial septostomy (Rashkind) for d-TGA with inadequate mixing.
• **Hypercyanotic (tet) spell**: knee-to-chest positioning, oxygen, IV fluids, opioid (morphine), phenylephrine to raise systemic vascular resistance, and beta blockade (propranolol/esmolol) to relax infundibular spasm.

Medical therapy for left-to-right shunt overcirculation

• Loop diuretic (furosemide) plus afterload reduction with an ACE inhibitor for pulmonary overcirculation, with high-calorie feeds for failure to thrive.
• Preterm hemodynamically significant PDA: COX inhibitors — indomethacin or ibuprofen — or acetaminophen; watch renal function and NEC risk.

Definitive repair

• Transcatheter device closure (secundum ASD, some PDAs), surgical patch closure (VSD, primum ASD/AVSD), complete TOF repair, **arterial switch (Jatene) for d-TGA, and staged Norwood → Glenn → Fontan** palliation for single-ventricle physiology, per the 2018 AHA/ACC adult congenital heart disease guideline and pediatric cardiac surgical practice.

Contraindicated

• COX inhibitors when the duct is the sole source of systemic or pulmonary flow.
• Shunt closure once Eisenmenger physiology with irreversible pulmonary vascular disease has developed (2018 AHA/ACC).
• ACE inhibitors and ARBs in pregnancy — all are fetotoxic, captopril included.
• Routine infective endocarditis prophylaxis: AHA limits it to unrepaired cyanotic CHD, the first 6 months after prosthetic-material repair, residual defects adjacent to prosthetic material, and prior endocarditis.

Emergencies

• Ductal closure in a ductal-dependent lesion: at 24–72 hours the duct constricts, producing sudden shock, metabolic acidosis, and absent femoral pulses (left-sided obstruction) or profound cyanosis (right-sided obstruction). Start prostaglandin E1 immediately.
• **Hypercyanotic tet spell**: catecholamine-driven infundibular spasm increases right-to-left shunt; the murmur paradoxically softens as flow across the RVOT falls. Untreated it causes syncope, seizure, and death.
• Paradoxical embolism through a PFO or right-to-left shunt: cryptogenic stroke in a young patient, or brain abscess in cyanotic CHD because the pulmonary filter is bypassed.

Disease-related

• Eisenmenger syndrome: chronic left-to-right shunt → pulmonary arteriolar remodeling → suprasystemic PVR → shunt reversal with cyanosis, clubbing, and secondary erythrocytosis; a loud, single, palpable P₂ signals it. Renders the defect inoperable.
• Infective endocarditis: turbulent jets injure endothelium; new murmur, fever, and embolic phenomena.
• Arrhythmia and sudden death: atrial reentry after atriotomy or Fontan; ventricular tachycardia late after TOF repair, heralded by progressive RV dilation from pulmonary regurgitation and QRS prolongation.
• Heart failure and failure to thrive from volume overload; systemic hypertension and recoarctation after coarctation repair; aortic dissection in Marfan or bicuspid-valve aortopathy.

Treatment-related

• Prostaglandin E1: apnea, hypotension, fever, and with prolonged use cortical hyperostosis.
• COX inhibitors for PDA: renal vasoconstriction with oliguria and rising creatinine, platelet dysfunction, and GI perforation/NEC.
• Surgical complete heart block after VSD or AVSD repair — the conduction axis runs along the posteroinferior rim of a perimembranous defect; may require pacing.
• Fontan circulation: passive pulmonary flow and chronically elevated venous pressure cause protein-losing enteropathy, plastic bronchitis, and Fontan-associated liver disease.

• Neural crest is the conotruncal cell: failed cardiac neural crest migration explains persistent truncus arteriosus, d-TGA, TOF, and interrupted aortic arch — and their clustering with 22q11.2 deletion (hypocalcemia, thymic aplasia). This is the single association examiners test most.
• The teratogen–lesion pairs: lithium → Ebstein anomaly; congenital rubella → PDA and pulmonary artery stenosis; pre-gestational maternal diabetes → d-TGA; alcohol → septal defects; retinoids and cocaine → conotruncal defects.
• Radiographic buzzwords: boot-shaped heart (TOF), egg-on-a-string (d-TGA), snowman/figure-of-8 (supracardiac TAPVR), figure-3 sign with rib notching (coarctation).
• Single best next step in a cyanotic or shocked neonate: prostaglandin E1 to reopen the ductus, then echocardiography — do not wait for imaging, and never give indomethacin.
• Differential cyanosis (pink upper body, blue lower body) means right-to-left ductal shunting distal to the left subclavian — coarctation, interrupted arch, or pulmonary hypertension. Reversed differential cyanosis (blue upper, pink lower) is essentially pathognomonic for d-TGA with coarctation or pulmonary hypertension.
• Arch derivatives worth memorizing: 3rd → carotids; left 4th → aortic arch; right 4th → proximal right subclavian; left 6th → ductus arteriosus (ligamentum arteriosum). This is why the left recurrent laryngeal nerve loops under the ductus/arch and the right loops under the right subclavian.
• ASD distractor: ostium secundum is the most common ASD and results from excess septum primum resorption or deficient septum secundum; ostium primum is an endocardial cushion defect and is the one tied to Down syndrome, with left axis deviation on ECG.
• Once Eisenmenger physiology develops, closure is contraindicated (2018 AHA/ACC) — the defect has become the pop-off valve for a suprasystemic pulmonary bed.